{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T21:16:48Z","timestamp":1762809408098,"version":"build-2065373602"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970949","82201068","82270983"],"award-info":[{"award-number":["81970949","82201068","82270983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.pdpdt.2023.103563","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T02:01:17Z","timestamp":1680919277000},"page":"103563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Developmental synergism in the management of oral potentially malignant disorders"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-9334","authenticated-orcid":false,"given":"Ya-Qin","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2023.103563_bib0001","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/odi.13704","article-title":"Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer","volume":"27","author":"Warnakulasuriya","year":"2021","journal-title":"Oral Dis."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0002","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/odi.13980","article-title":"Management of oral potentially malignant disorders","volume":"27","author":"Kerr","year":"2021","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103563_bib0003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/154411130301400105","article-title":"Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics","volume":"14","author":"Reibel","year":"2003","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0004","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jop.12726","article-title":"Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis","volume":"47","author":"Mello","year":"2018","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1600-0714.2007.00582.x","article-title":"Nomenclature and classification of potentially malignant disorders of the oral mucosa","volume":"36","author":"Warnakulasuriya","year":"2007","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0006","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hed.26006","article-title":"Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype","volume":"42","author":"Iocca","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0007","first-page":"e59","article-title":"A clinical diagnosis of oral leukoplakia\u2014a guide for dentists","volume":"23","author":"Carrard","year":"2018","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0008","first-page":"e799","article-title":"Oral leukoplakia; a proposal for simplification and consistency of the clinical classification and terminology","volume":"24","author":"van der Waal","year":"2019","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0009","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/odi.12781","article-title":"Oral leukoplakia remains a challenging condition","volume":"24","author":"Villa","year":"2018","journal-title":"Oral Dis."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0010","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.oraloncology.2015.09.004","article-title":"Long-term outcome of non-surgical treatment in patients with oral leukoplakia","volume":"51","author":"Kuribayashi","year":"2015","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0011","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/odi.13831","article-title":"Malignant transformation of oral proliferative verrucous leukoplakia: a systematic review and meta-analysis","volume":"27","author":"Ramos-Garcia","year":"2021","journal-title":"Oral Dis."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0012","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/odi.12095","article-title":"Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients","volume":"20","author":"Brouns","year":"2014","journal-title":"Oral Dis."},{"issue":"3","key":"10.1016\/j.pdpdt.2023.103563_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0714.2007.00584.x","article-title":"Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement","volume":"37","author":"Warnakulasuriya","year":"2008","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0014","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.4317\/medoral.21007","article-title":"Oral leukoplakia, the ongoing discussion on definition and terminology","volume":"20","author":"van der Waal","year":"2015","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0015","article-title":"Interventions for treating oral leukoplakia to prevent oral cancer","volume":"7","author":"Lodi","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.102713","article-title":"Photodynamic therapy for oral potentially malignant disorders: a systematic review and meta-analysis","volume":"37","author":"Binnal","year":"2022","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0017","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/odi.12443","article-title":"Oral leukoplakia-to treat or not to treat","volume":"22","author":"Holmstrup","year":"2016","journal-title":"Oral Dis."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0018","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0714.2007.00575.x","article-title":"Management of potentially malignant disorders: evidence and critique","volume":"37","author":"Lodi","year":"2008","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0019","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","article-title":"Photodynamic therapy - mechanisms, photosensitizers and combinations","volume":"106","author":"Kwiatkowski","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pdpdt.2018.10.023","article-title":"Photodynamic therapy in the treatment of oral leukoplakia: a systematic review","volume":"25","author":"Li","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/jicd.12270","article-title":"Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region: a systematic review","volume":"9","author":"Gondivkar","year":"2018","journal-title":"J. Investig. Clin. Dent."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0022","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jfma.2015.03.013","article-title":"Topical photodynamic therapy is the first-line treatment of choice for oral erythroleukoplakia and oral verrucous hyperplasia","volume":"114","author":"Chen","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0023","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3389\/fphys.2018.01911","article-title":"Primary clinical evaluation of photodynamic therapy with oral leukoplakia in Chinese patients","volume":"9","author":"Han","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0024","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/lsm.20214","article-title":"Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy","volume":"37","author":"Chen","year":"2005","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102340","article-title":"Chinese guidelines on the clinical application of 5-aminolevulinic acid-based photodynamic therapy in dermatology (2021 edition)","volume":"35","author":"Shi","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0026","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archoto.2011.178","article-title":"Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia","volume":"137","author":"Shafirstein","year":"2011","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101888","article-title":"Photodynamic therapy using topical toluidine blue for the treatment of oral leukoplakia: a prospective case series","volume":"31","author":"Di Stasio","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0028","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/lio2.772","article-title":"Effects of methylene blue photodynamic therapy on oral carcinoma and leukoplakia cells","volume":"7","author":"Le","year":"2022","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0029","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pdpdt.2013.10.003","article-title":"Clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia","volume":"11","author":"Pietruska","year":"2014","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0030","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1017\/S0022215100125496","article-title":"Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity","volume":"107","author":"Grant","year":"1993","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101782","article-title":"Role of nanocarriers in photodynamic therapy","volume":"30","author":"Qidwai","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0032","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/jdv.15185","article-title":"A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis","volume":"33","author":"Dirschka","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0033","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/jdv.16247","article-title":"5-Aminolevulinic acid patch (Alacare) photodynamic therapy for actinic cheilitis: data from a prospective 12-month follow-up study on 21 patients","volume":"34","author":"Radakovic","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119554","article-title":"A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid","volume":"586","author":"Champeau","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1600-0714.2010.00935.x","article-title":"Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia","volume":"39","author":"Lin","year":"2010","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0036","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pdpdt.2019.08.005","article-title":"Photodynamic therapy for oral potentially malignant disorders","volume":"28","author":"Jin","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102523","article-title":"Ablative fractional laser-assisted photodynamic therapy vs. ablative fractional laser for oral leukoplakia treatment: a randomized, controlled pilot study","volume":"36","author":"Yao","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0038","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pdpdt.2017.10.006","article-title":"Treatment of oral refractory large area mucosal leukoplakia with CO2 laser combined with photodynamic therapy: case report","volume":"20","author":"Zhang","year":"2017","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0039","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4103\/0973-1482.147703","article-title":"Treatment of oral leukoplakia with photodynamic therapy: a pilot study","volume":"11","author":"Selvam","year":"2015","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0040","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/odi.13036","article-title":"MAL-PDT inhibits oral precancerous cells and lesions via autophagic cell death","volume":"25","author":"Wang","year":"2019","journal-title":"Oral Dis."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0041","first-page":"925","article-title":"Current methods for photodynamic therapy in the US: comparison of MAL\/PDT and ALA\/PDT","volume":"25","author":"Lee","year":"2013","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0042","first-page":"250","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0043","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lsm.22429","article-title":"mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: case and literature review","volume":"47","author":"Horlings","year":"2015","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0044","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1021\/cr5004198","article-title":"Nanoparticles in photodynamic therapy","volume":"115","author":"Lucky","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0045","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3109\/10717544.2016.1165310","article-title":"Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma","volume":"23","author":"Qidwai","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0046","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jphotobiol.2013.11.007","article-title":"Preparation and characterization of mTHPC-loaded solid lipid nanoparticles for photodynamic therapy","volume":"130","author":"Navarro","year":"2014","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0047","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12951-022-01310-2","article-title":"Multifunctional photodynamic\/photothermal nano-agents for the treatment of oral leukoplakia","volume":"20","author":"Lin","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0048","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1002\/anie.201802497","article-title":"An assembled nanocomplex for improving both therapeutic efficiency and treatment depth in photodynamic therapy","volume":"57","author":"Cao","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0049","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10717544.2018.1435751","article-title":"Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy","volume":"25","author":"Guo","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biomaterials.2017.02.017","article-title":"Orthogonal near-infrared upconversion co-regulated site-specific O2 delivery and photodynamic therapy for hypoxia tumor by using red blood cell microcarriers","volume":"125","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0051","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/adfm.201504803","article-title":"Red blood cell-facilitated photodynamic therapy for cancer treatment","volume":"26","author":"Tang","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0052","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1039\/C8TB01844H","article-title":"Perfluorocarbon-based O2 nanocarrier for efficient photodynamic therapy","volume":"7","author":"Hu","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0053","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1021\/acsnano.9b01087","article-title":"Catalase-integrated hyaluronic acid as nanocarriers for enhanced photodynamic therapy in solid tumor","volume":"13","author":"Phua","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0054","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biomaterials.2018.08.011","article-title":"Photosensitizer-crosslinked in-situ polymerization on catalase for tumor hypoxia modulation & enhanced photodynamic therapy","volume":"181","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0055","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1021\/acs.nanolett.9b00934","article-title":"Biomimetic hybrid nanozymes with self-supplied H+ and accelerated O2 generation for enhanced starvation and photodynamic therapy against hypoxic tumors","volume":"19","author":"Yang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0056","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/acsnano.7b07746","article-title":"Nanozyme decorated metal-organic frameworks for enhanced photodynamic therapy","volume":"12","author":"Zhang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0057","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biomaterials.2018.12.017","article-title":"A two-photon excited O2-evolving nanocomposite for efficient photodynamic therapy against hypoxic tumor","volume":"194","author":"Li","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0058","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2016.03.037","article-title":"Activatable albumin-photosensitizer nanoassemblies for triple-modal imaging and thermal-modulated photodynamic therapy of cancer","volume":"93","author":"Hu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0059","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/acs.nanolett.6b00068","article-title":"Hyaluronidase to enhance nanoparticle-based photodynamic tumor therapy","volume":"16","author":"Gong","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0060","doi-asserted-by":"crossref","first-page":"43493","DOI":"10.1021\/acsami.8b17684","article-title":"Collagenase-encapsulated ph-responsive nanoscale coordination polymers for tumor microenvironment modulation and enhanced photodynamic nanomedicine","volume":"10","author":"Liu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0061","article-title":"A photosensitive polymeric carrier with a renewable singlet oxygen reservoir regulated by two nir beams for enhanced antitumor phototherapy","volume":"17","author":"Yang","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0062","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1021\/acs.nanolett.0c00047","article-title":"Self-delivery nanomedicine for O2-economized photodynamic tumor therapy","volume":"20","author":"Zhao","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0063","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1039\/C6CS00616G","article-title":"Overcoming the Achilles' heel of photodynamic therapy","volume":"45","author":"Fan","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0064","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1751-1097.2004.tb00044.x","article-title":"Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors","volume":"80","author":"Bisland","year":"2004","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0065","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1021\/acsnano.0c00675","article-title":"Human motion driven self-powered photodynamic system for long-term autonomous cancer therapy","volume":"14","author":"Liu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0066","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41551-018-0261-7","article-title":"Tissue-adhesive wirelessly powered optoelectronic device for metronomic photodynamic cancer therapy","volume":"3","author":"Yamagishi","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0067","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1364\/BOE.1.001480","article-title":"Illumination devices for photodynamic therapy of the oral cavity","volume":"1","author":"Canavesi","year":"2010","journal-title":"Biomed. Opt. Express"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0068","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.oraloncology.2017.02.014","article-title":"Topical agents for oral cancer chemoprevention: a systematic review of the literature","volume":"67","author":"Chau","year":"2017","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0069","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<921::AID-CNCR5>3.0.CO;2-6","article-title":"Topical application of vitamin A to oral leukoplakia: a clinical case series","volume":"86","author":"Epstein","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1368-8375(98)00095-5","article-title":"Bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study","volume":"35","author":"Piattelli","year":"1999","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0071","first-page":"411","article-title":"The role of apoptosis and bcl-2 protein in topical treatment of oral leukoplakia with isotretinoin","volume":"48","author":"Tet\u00e8","year":"1999","journal-title":"Minerva Stomatol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0072","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0002-9610(83)90232-5","article-title":"Effect of retinoids on oral leukoplakia","volume":"146","author":"Shah","year":"1983","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0073","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1200\/JCO.2003.03.544","article-title":"An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia","volume":"21","author":"Rudin","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0074","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1158\/1078-0432.CCR-1020-3","article-title":"Randomized, double-blind, placebo-controlled Phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia","volume":"10","author":"Mulshine","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0075","first-page":"218","article-title":"The chemopreventive effects of tea on human oral precancerous mucosa lesions","volume":"220","author":"Li","year":"1999","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0076","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.oraloncology.2009.06.004","article-title":"Chemoprevention of oral cancer in animal models, and effect on leukoplakias in human patients with ZengShengPing, a mixture of medicinal herbs","volume":"46","author":"Sun","year":"2010","journal-title":"Oral Oncol."},{"issue":"5","key":"10.1016\/j.pdpdt.2023.103563_bib0077","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/1940-6207.CAPR-13-0004","article-title":"Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial","volume":"6","author":"Armstrong","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0078","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0964-1955(97)00010-9","article-title":"Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment","volume":"33","author":"Sankaranarayanan","year":"1997","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0079","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0304-3835(88)90266-2","article-title":"Response of oral leukoplakias to the administration of vitamin A","volume":"40","author":"Stich","year":"1988","journal-title":"Cancer Lett."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0080","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198612113152401","article-title":"13-cis-retinoic acid in the treatment of oral leukoplakia","volume":"315","author":"Hong","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0081","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/ijc.29156","article-title":"Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial","volume":"136","author":"Nagao","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0082","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0714.2010.00991.x","article-title":"Lycopene: features and potential significance in the oral cancer and precancerous lesions","volume":"40","author":"Lu","year":"2011","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0083","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.oraloncology.2003.12.011","article-title":"Efficacy of oral lycopene in the treatment of oral leukoplakia","volume":"40","author":"Singh","year":"2004","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0084","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2334\/josnusd.52.251","article-title":"Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress","volume":"52","author":"Rai","year":"2010","journal-title":"J. Oral Sci."},{"issue":"12","key":"10.1016\/j.pdpdt.2023.103563_bib0085","first-page":"4684","article-title":"Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial","volume":"6","author":"Armstrong","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0086","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1158\/1078-0432.CCR-07-4024","article-title":"Pilot randomized phase II study of celecoxib in oral premalignant lesions","volume":"14","author":"Papadimitrakopoulou","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0087","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1158\/1940-6207.CAPR-09-0121","article-title":"Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions","volume":"2","author":"Tsao","year":"2009","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0088","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jnci\/djz238","article-title":"Oral leukoplakia and risk of progression to oral cancer: a population-based cohort study","volume":"112","author":"Chaturvedi","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0089","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.oraloncology.2005.08.011","article-title":"Long-term treatment outcome of oral premalignant lesions","volume":"42","author":"Holmstrup","year":"2006","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0090","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1368-8375(98)80007-9","article-title":"Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands","volume":"34","author":"Schepman","year":"1998","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0091","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-0714.2012.01167.x","article-title":"Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy","volume":"41","author":"Kuribayashi","year":"2012","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0092","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/odi.13747","article-title":"Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: a systematic review","volume":"27","author":"Monteiro","year":"2021","journal-title":"Oral Dis."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0093","first-page":"e520","article-title":"Type of surgical treatment and recurrence of oral leukoplakia: a retrospective clinical study","volume":"22","author":"Monteiro","year":"2017","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0094","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hed.21912","article-title":"Cryogun cryotherapy for oral leukoplakia","volume":"34","author":"Lin","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/jop.12287","article-title":"Cryogun cryotherapy for oral leukoplakia and adjacent melanosis lesions","volume":"44","author":"Chen","year":"2015","journal-title":"J. Oral Pathol. Med."},{"issue":"5","key":"10.1016\/j.pdpdt.2023.103563_bib0096","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jfma.2014.01.014","article-title":"Cryotherapy for oral precancers and cancers","volume":"113","author":"Yu","year":"2014","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0097","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1368-8375(99)00022-6","article-title":"Carbon dioxide laser evaporation of leukoplakia of the lower lip: a retrospective evaluation","volume":"35","author":"Gooris","year":"1999","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0098","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.oraloncology.2004.06.010","article-title":"The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up","volume":"41","author":"van der Hem","year":"2005","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0099","first-page":"e237","article-title":"Outcome of CO2 laser vaporization for oral potentially malignant disorders treatment","volume":"23","author":"Cloitre","year":"2018","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.joms.2009.03.028","article-title":"Treatment of oral leukoplakia with carbon dioxide and potassium-titanyl-phosphate lasers: a comparison","volume":"68","author":"Lim","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0101","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/pho.2018.4491","article-title":"Treatment outcome of oral leukoplakia with Er:YAG laser: a 5-year follow-up prospective comparative study","volume":"36","author":"Arduino","year":"2018","journal-title":"Photomed. Laser Surg."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0102","doi-asserted-by":"crossref","first-page":"120","DOI":"10.15171\/jlms.2015.05","article-title":"Efficacy of diode laser for the management of potentially malignant disorders","volume":"6","author":"Reddy Kundoor","year":"2015","journal-title":"J. Lasers Med. Sci."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0103","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s10103-013-1266-9","article-title":"Er,Cr:YSGG laser therapy for oral leukoplakia minimizes thermal artifacts on surgical margins: a pilot study","volume":"28","author":"Seoane","year":"2013","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0104","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0039-1688846","article-title":"Diode laser and fractional laser innovations","volume":"35","author":"Archer","year":"2019","journal-title":"Fac. Plast. Surg."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0105","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.4317\/medoral.17960","article-title":"Comparison of pain and swelling after removal of oral leukoplakia with CO2 laser and cold knife: a randomized clinical trial","volume":"18","author":"Lopez-Jornet","year":"2013","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104850","article-title":"Laser excision of oral leukoplakia: does it affect recurrence and malignant transformation? A systematic review and meta-analysis","volume":"109","author":"de Pauli Paglioni","year":"2020","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0107","first-page":"e779","article-title":"A comparative evaluation: oral leukoplakia surgical management using diode laser, CO2 laser, and cryosurgery","volume":"9","author":"Natekar","year":"2017","journal-title":"J. Clin. Exp. Dent."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0108","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10103-011-0910-5","article-title":"Different CO2 laser vaporization protocols for the therapy of oral precancerous lesions and precancerous conditions: a 10-year follow-up","volume":"27","author":"Deppe","year":"2012","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0109","first-page":"e209","article-title":"CO2 laser ablation of oral leukoplakia: with or without extension of margins?","volume":"171","author":"Romeo","year":"2020","journal-title":"Clin. Ter."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/pho.2016.4256","article-title":"Evaluation of different laser-supported surgical protocols for the treatment of oral leukoplakia: a long-term follow-up","volume":"35","author":"Nammour","year":"2017","journal-title":"Photomed. Laser Surg."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2019.101597","article-title":"The combination of photodynamic therapy and fractional CO2 laser for oral leukoplakia: case series","volume":"29","author":"Yao","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0112","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/lsm.23534","article-title":"Management of oral leukoplakia by ablative fractional laser-assisted photodynamic therapy: a 3-year retrospective study of 48 patients","volume":"54","author":"Yao","year":"2022","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102564","article-title":"Photodynamic therapy combined with laser drilling successfully prevents the recurrence of refractory oral proliferative verrucous leukoplakia","volume":"36","author":"Wang","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0114","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pdpdt.2016.06.012","article-title":"Plum-blossom needling promoted PpIX fluorescence intensity from 5-aminolevulinic acid in porcine skin model and patients with actnic keratosis","volume":"15","author":"Chen","year":"2016","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jamadermatol.2017.0849","article-title":"Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses: a randomized clinical trial","volume":"153","author":"Petukhova","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0116","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pdpdt.2019.01.011","article-title":"Plum-blossom needle assisted photodynamic therapy for the treatment of oral potentially malignant disorder in the elderly","volume":"25","author":"Wang","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamaoncol.2015.4364","article-title":"Erlotinib and the risk of oral cancer: the Erlotinib Prevention of Oral Cancer (EPOC) randomized clinical trial","volume":"2","author":"William","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0118","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1601-0825.1995.tb00158.x","article-title":"Effect of cessation of tobacco use on the incidence of oral mucosal lesions in a 10-yr follow-up study of 12,212 users","volume":"1","author":"Gupta","year":"1995","journal-title":"Oral Dis."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0119","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1097-0215(20001001)88:1<129::AID-IJC20>3.0.CO;2-U","article-title":"Alcohol drinking body mass index and the risk of oral leukoplakia in an Indian population","volume":"88","author":"Hashibe","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.oraloncology.2010.01.017","article-title":"Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: a case-control study","volume":"46","author":"Amarasinghe","year":"2010","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0121","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/hed.25138","article-title":"Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia","volume":"40","author":"Shingler","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0122","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.oooo.2021.03.009","article-title":"Management of oral leukoplakia: a position paper of the Society of Oral Medicine, Chinese Stomatological Association","volume":"132","author":"Chen","year":"2021","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0123","first-page":"884","article-title":"Standardized diagnosis and treatment of oral leukoplakia","volume":"57","author":"Wei","year":"2022","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"key":"10.1016\/j.pdpdt.2023.103563_bib0124","doi-asserted-by":"crossref","first-page":"799","DOI":"10.17219\/acem\/32488","article-title":"Photodynamic therapy as a promising method used in the treatment of oral diseases","volume":"25","author":"Pra\u017cmo","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pdpdt.2011.12.007","article-title":"Comparison of cryotherapy and photodynamic therapy in treatment of oral leukoplakia","volume":"9","author":"Kawczyk-Krupka","year":"2012","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0126","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pdpdt.2013.10.003","article-title":"Clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia","volume":"11","author":"Pietruska","year":"2014","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2023.103563_bib0127","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41368-019-0047-0","article-title":"Photodynamic therapy guidelines for the management of oral leucoplakia","volume":"11","author":"Chen","year":"2019","journal-title":"Int. J. Oral Sci."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100023002909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100023002909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:55:04Z","timestamp":1761612904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100023002909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":127,"alternative-id":["S1572100023002909"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103563","relation":{},"ISSN":["1572-1000"],"issn-type":[{"type":"print","value":"1572-1000"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developmental synergism in the management of oral potentially malignant disorders","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103563"}}